Expanded Positive Coverage for Centinel Spine’s prodisc L

Centinel Spine announced expansion of coverage for lumbar total disc replacement (TDR) procedures in the Mid-Atlantic region of the U.S.

The policy expansion announced by New Jersey’s largest commercial payor represents over 2.3 million covered lives across the state and includes a positive coverage recommendation for both one- and two-level lumbar TDR. Because prodisc L is the only lumbar TDR device with FDA approval for two-level use, the two-level coverage recommendation applies exclusively to the use of the prodisc L device.

Additionally, the largest commercial payor in the Philadelphia tri-state area has established positive coverage for both one- and two-level lumbar TDR. This represents over 850,000 covered lives.

With this favorable coverage expansion in the Mid-Atlantic region, it is estimated that commercial coverage in the U.S. for one-level lumbar TDR has grown from 50% of covered lives in 2017 to nearly 95% today. Commercial coverage in the U.S. for two-level lumbar TDR is now over 35%.

Centinel Spine CEO Steve Murray shared, “It’s encouraging to see the top commercial payors in the Philadelphia and New Jersey areas provide much needed one- and two-level lumbar total disc replacement access to a significant number of individuals. Commercial coverage for 1-level lumbar disc procedures is close to universal at this point. And we are further encouraged by the nationwide acceleration of coverage for 2-level lumbar disc replacement procedures as it was essentially non-existent several years ago. The long-term safety and clinical benefits of lumbar total disc replacement are indisputable, and the procedure is an excellent option for many patients. We are inspired by the continually improving environment we see for total disc replacement in spine care.”

Source: Centinel Spine, LLC